Migraine: a review and future directions for treatment (Q36546603)

14 August 2017

1 reference

title

Migraine: a review and future directions for treatment (English)

1 reference

14 August 2017

Linde M

1

1 reference

PubMed ID

16867028

14 August 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

Acta Neurologica Scandinavica

14 August 2017

1 reference

14 August 2017

114

1 reference

14 August 2017

2

1 reference

14 August 2017

71-83

1 reference

The diagnostic value of historical features in primary headache syndromes: a comprehensive review

14 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Attitudes and burden of disease among self-considered migraineurs--a nation-wide population-based survey in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

One-year prevalence of migraine in Sweden: a population-based study in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

The impact of migraine on quality of life in the general population: the GEM study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Quality of life differs among headache diagnoses: analysis of SF-36 survey in 901 headache patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Population-based door-to-door survey of migraine in Japan: the Daisen study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

A nationwide survey of migraine in France: prevalence and clinical features in adults. GRIM

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Premonitory symptoms in migraine: an electronic diary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

The premonitory symptoms (prodrome): a tertiary care study of 893 migraineurs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Clinical characteristics of 362 patients with familial migraine with aura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Migraine Postdromes: Symptoms After Attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Reversible cognitive decline accompanies migraine and cluster headaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Cognitive disturbances and regional cerebral blood flow abnormalities in migraine patients: their relationship with the clinical manifestations of the illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Impact of antimigraine compounds on cognitive processing: a placebo-controlled crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Familial occurrence of headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Recent findings in headache genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Contemporary concepts of migraine pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Contrasts in cortical magnesium, phospholipid and energy metabolism between migraine syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Electrophysiological Studies in Migraine: A Comprehensive Review of Their Interest and Limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Therapeutic implications of central and peripheral neurologic mechanisms in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Visual system dysfunction in migraine: a review of clinical and psychophysical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Balance disorders in headache patients: evaluation by computerized static stabilometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Astroglia and glutamate in physiology and pathology: aspects on glutamate transport, glutamate-induced cell swelling and gap-junction communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Brain stem activation in spontaneous human migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

A positron emission tomographic study in spontaneous migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Regulation of regional cerebral blood flow during and between migraine attacks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Migraine aura: new information on underlying mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

5-Hydroxytryptamine and glutamate modulate velocity and extent of intercellular calcium signalling in hippocampal astroglial cells in primary cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Focal headache during balloon inflation in the internal carotid and middle cerebral arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Timing and topography of cerebral blood flow, aura, and headache during migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Magnetic resonance angiography in facial and other pain: neurovascular mechanisms of trigeminal sensation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Migraine can be induced by sildenafil without changes in middle cerebral artery diameter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Calcitonin gene-related peptide (CGRP) and the pathophysiology of headache: therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Retinal plasma extravasation in animals but not in humans: implications for the pathophysiology of migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Impairment of parasympathetic baroreflex responses in migraine patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Self-awareness of migraine: interpreting the labels that headache sufferers apply to their headaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Migraine patients experience poorer subjective well-being/quality of life even between attacks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Migraine history and migraine-induced stroke in the Dijon stroke registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Sumatriptan plus metoclopramide in triptan-nonresponsive migraineurs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Efficacy and tolerability of prochlorperazine buccal tablets in treatment of acute migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

The efficacy of metoclopramide in the treatment of migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomised, three-attack study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Gastric motor effects of triptans: open questions and future perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Zolmitriptan nasal spray provides fast relief of migraine symptoms and is preferred by patients: a Swedish study of preference in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

No effect of eletriptan administration during the aura phase of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Sumatriptan (5-HT1B/1D-agonist) causes a transient allodynia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Role of the needling per se in acupuncture as prophylaxis for menstrually related migraine: a randomized placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Propranolol in the management of recurrent migraine: a meta-analytic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Topiramate for migraine prevention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Migraine prophylaxis. A comparison of propranolol and amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Petasites hybridus root (butterbur) is an effective preventive treatment for migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Efficacy of gabapentin in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Migraine prophylactic medication usage patterns in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Improving patient compliance to prophylactic migraine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

The doctor and the migraine patient: improving compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Psychological treatments for migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Ethical aspects of placebo in migraine research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Behavioral and prophylactic pharmacological intervention studies of pediatric migraine: an exploratory meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Aerobic exercise and plasma beta endorphin levels in patients with migrainous headache without aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

The effects of exercise and exercise-related changes in blood nitric oxide level on migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Effectiveness of multidisciplinary intervention in the treatment of migraine: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Acupuncture in the prophylactic treatment of migraine without aura: a comparison with flunarizine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Acupuncture for patients with migraine: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Physical treatments for headache: a structured review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Some clinical features of the acute migraine attack. An analysis of 750 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Interictal and Postictal Cognitive Changes in Migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

Subcutaneous sumatriptan during the migraine aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2006.00670.X

10.1111/J.1600-0404.2006.00670.X

21 January 2018

Identifiers

DOI

1 reference

release_uqiar3h6yzalbodtgfkkz3kf2m

14 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uqiar3h6yzalbodtgfkkz3kf2m

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

16867028

1 reference

PubMed ID

16867028